Are GLP-1 Receptor Agonists Safe for the Eyes?

GLP-1 receptor agonists, commonly prescribed for diabetes management, are now under scrutiny for potential eye-related side effects like nonarteritic anterior ischemic optic neuropathy. This has raised concerns about whether these benefits outweigh the risks, especially for patients with pre-existing eye conditions. Understanding these implications is crucial for both healthcare providers and patients, as it could influence treatment decisions and monitoring strategies to ensure the safest possible outcomes.